Pharmalogic Ltd - Period Ending 2021-03-31

Pharmalogic Ltd - Period Ending 2021-03-31


Pharmalogic Ltd 05338782 false 2020-04-01 2021-03-31 2021-03-31 The principal activity of the company is consultancy services in the pharmaceutical industry Digita Accounts Production Advanced 6.29.9459.0 Software true 05338782 2020-04-01 2021-03-31 05338782 2021-03-31 05338782 core:RetainedEarningsAccumulatedLosses 2021-03-31 05338782 core:ShareCapital 2021-03-31 05338782 core:CurrentFinancialInstruments 2021-03-31 05338782 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 05338782 core:OfficeEquipment 2021-03-31 05338782 bus:SmallEntities 2020-04-01 2021-03-31 05338782 bus:AuditExemptWithAccountantsReport 2020-04-01 2021-03-31 05338782 bus:FullAccounts 2020-04-01 2021-03-31 05338782 bus:SmallCompaniesRegimeForAccounts 2020-04-01 2021-03-31 05338782 bus:RegisteredOffice 2020-04-01 2021-03-31 05338782 bus:Director1 2020-04-01 2021-03-31 05338782 bus:PrivateLimitedCompanyLtd 2020-04-01 2021-03-31 05338782 core:OfficeEquipment 2020-04-01 2021-03-31 05338782 countries:AllCountries 2020-04-01 2021-03-31 05338782 2020-03-31 05338782 core:OfficeEquipment 2020-03-31 05338782 2019-04-01 2020-03-31 05338782 2020-03-31 05338782 core:RetainedEarningsAccumulatedLosses 2020-03-31 05338782 core:ShareCapital 2020-03-31 05338782 core:CurrentFinancialInstruments 2020-03-31 05338782 core:CurrentFinancialInstruments core:WithinOneYear 2020-03-31 05338782 core:OfficeEquipment 2020-03-31 iso4217:GBP xbrli:pure

Registration number: 05338782

Pharmalogic Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2021

 

Pharmalogic Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 5

 

Pharmalogic Ltd

(Registration number: 05338782)
Balance Sheet as at 31 March 2021

Note

2021
£

2020
£

Fixed assets

 

Tangible assets

4

789

1,051

Current assets

 

Debtors

5

44,780

42,674

Cash at bank and in hand

 

150,365

214,075

 

195,145

256,749

Creditors: Amounts falling due within one year

6

(65,144)

(115,716)

Net current assets

 

130,001

141,033

Net assets

 

130,790

142,084

Capital and reserves

 

Called up share capital

2

2

Profit and loss account

130,788

142,082

Total equity

 

130,790

142,084

For the financial year ending 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 28 September 2021
 

.........................................

P D Brash
Director

 

Pharmalogic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
2 Old Bath Road
Newbury
Berkshire
RG14 1QL
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Tax

The tax expense for the period comprises current tax payable.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% reducing balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Pharmalogic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

Debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2020 - 1).

 

Pharmalogic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

4

Tangible assets

Office equipment
£

Total
£

Cost or valuation

At 1 April 2020

1,073

1,073

At 31 March 2021

1,073

1,073

Depreciation

At 1 April 2020

22

22

Charge for the year

262

262

At 31 March 2021

284

284

Carrying amount

At 31 March 2021

789

789

At 31 March 2020

1,051

1,051

5

Debtors

2021
£

2020
£

Trade debtors

44,780

40,474

Other debtors

-

2,200

44,780

42,674

6

Creditors

Creditors: amounts falling due within one year

2021
£

2020
£

Due within one year

Trade creditors

210

210

Taxation and social security

39,320

95,246

Other creditors

25,614

20,260

65,144

115,716

 

Pharmalogic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2021

7

Related party transactions

Other transactions with directors

P Brash had a loan with the company. At the balance sheet date the amount due to P Brash was £25,614 (2020: £20,260).